About Tesio

Tesio is Developing the Next Generation of Anti-inflammatory Products with Kinase Inhibition and State-of-the-art Targeted Drug Delivery

Our technology targets the master checkpoint common to all inflammatory pathways to outperform conventional therapeutics

Targeted long-acting injections provide relief without systemic exposure or steroid side-effects

Lead indication is Osteoarthritis, the nation’s most common cause of disability